Skip to main content

Kenya Stakeholders Consultation, August 30, 2024

MATRIX convened an in-country consultation with stakeholders in Nairobi, Kenya, August 30, 2024. Below are the documents and presentations from this meeting.

Images from the meeting can be viewed here.

DescriptionDateSize
Documents
Agenda (Download) 2024-08-30380.39 KB
Presentations
1 - MATRIX: Developing the next generation of HIV prevention products for women (Download) 2024-08-304.64 MB
2 - Tenofovir Alafenamide / Elvitegravir (TAF/EVG) Fast Dissolving Insert (Download) 2024-08-302.15 MB
3 - Monthly Dapivirine Vaginal Film and Monthly Dapivirine Dual-Purpose Film (Download) 2024-08-302 MB
4 - Non-ARV/Nonhormonal Contraceptive Dual-Purpose Vaginal Ring and MATRIX-003 (Download) 2024-08-301.97 MB
5 - Critical Pathway Products: Regulatory, Cost & Manufacturing Considerations (Download) 2024-08-301017.68 KB
6 - The CARE PrEP Study (MATRIX-007) Evaluating the safety of CAB-LA, the dapivirine ring and oral PrEP during pregnancy (Download) 2024-08-301.66 MB
7 - MATRIX and the Framework for HIV Prevention in Kenya (Download) 2024-08-301.62 MB